GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (FRA:5HZ1) » Definitions » Interest Expense

Hangzhou Tigermed Consulting Co (FRA:5HZ1) Interest Expense : €-0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hangzhou Tigermed Consulting Co's interest expense for the three months ended in Mar. 2024 was € 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hangzhou Tigermed Consulting Co's Operating Income for the three months ended in Mar. 2024 was € 44.5 Mil. Hangzhou Tigermed Consulting Co's Interest Expense for the three months ended in Mar. 2024 was € 0.0 Mil. GuruFocus does not calculate Hangzhou Tigermed Consulting Co's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hangzhou Tigermed Consulting Co Interest Expense Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Interest Expense Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.19 -6.38 -3.46 -11.26 -15.40

Hangzhou Tigermed Consulting Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.01 -

Hangzhou Tigermed Consulting Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co  (FRA:5HZ1) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hangzhou Tigermed Consulting Co's Interest Expense for the three months ended in Mar. 2024 was €0.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was €44.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €107.6 Mil.

Hangzhou Tigermed Consulting Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

GuruFocus does not calculate Hangzhou Tigermed Consulting Co's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Hangzhou Tigermed Consulting Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Hangzhou Tigermed Consulting Co (FRA:5HZ1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (FRA:5HZ1) » Definitions » Interest Expense
Comparable Companies
SHSE:603882 SZSE:300676 SHSE:603127 SZSE:300244 SHSE:603108 SZSE:300406 SZSE:300463 SZSE:300685 SZSE:300396 SZSE:300639 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
HNGZY:USA 03347:Hong Kong 300347:China
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Website
https://www.tigermed.net
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (FRA:5HZ1) Headlines

No Headlines